Wenjun Li

Wenjun Li

Auto-generated profile, based on publicly available information

Wenjun Li

Surgery, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Science Advances
Verified
Journal Article
Open access
FKFatima Zohra Khamissi
Fatima Zohra Khamissi
LNLiang Ning
Liang Ning
EKEirini Kefalogianni
Eirini Kefalogianni
HDHao Dun
Hao Dun
AAAkshayakeerthi Arthanarisami
Akshayakeerthi Arthanarisami
AHAndreas Herrlich
Andreas Herrlich
Tissue injury can drive secondary organ injury; however, mechanisms and mediators are not well understood. To identify interorgan cross-talk mediators, we used acute kidney injury (AKI)–induced acute lung injury (ALI) as a clinically important example. Using kidney and lung single-cell RNA sequencing after AKI in mice followed by ligand-receptor pairing analysis across organs, kidney ligands to lung receptors, we identify kidney-released circulating osteopontin (OPN) as a novel AKI-ALI mediator. OPN release from kidney tubule cells triggered lung endothelial leakage, inflammation, and respiratory failure. Pharmacological or genetic OPN inhibition prevented AKI-ALI. Transplantation of ischemic wt kidneys caused AKI-ALI, but not of ischemic OPN–global knockout kidneys, identifying kidney-released OPN as necessary interorgan signal to cause AKI-ALI. We show that OPN serum levels are elevated in patients with AKI and correlate with kidney injury. Our results demonstrate feasibility of using ligand-receptor analysis across organs to identify interorgan cross-talk mediators and may have important therapeutic implications in human AKI-ALI and multiorgan failure.

14 June 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ZZZhikun Zheng
Zhikun Zheng
SCStephen Chiu
Stephen Chiu
MAMahzad Akbarpour
Mahzad Akbarpour
HSHaiying Sun
Haiying Sun
PRPaul A. Reyfman
Paul A. Reyfman
ABAnkit Bharat
Ankit Bharat
Donor nonclassical monocytes mediate primary lung allograft dysfunction by recruiting neutrophils via MyD88-dependent production of CXCL2.

1 March 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
WLWenjun Li
Wenjun Li
YTYuriko Terada
Yuriko Terada
YTYulia Y. Tyurina
Yulia Y. Tyurina
VTVladimir A. Tyurin
Vladimir A. Tyurin
ABAmit I. Bery
Amit I. Bery
DKDaniel Kreisel
Daniel Kreisel
Significance: Intravital imaging, oxidative lipidomics, and a transplant model were used to define mechanisms that regulate neutrophil recruitment into lungs during ischemia reperfusion injury, a clinically relevant form of sterile inflammation. We found that early neutrophil-mediated damage is largely confined to the subpleural vasculature, a process that is orchestrated by a spatially restricted distribution of nonclassical monocytes that produce chemokines following necroptosis of pulmonary cells. Neutrophils disrupt the integrity of subpleural capillaries, which is associated with impaired lung function. Neutrophil-mediated vascular leakage is dependent on TLR4 expression on vascular endothelium, NOX4 signaling, and formation of neutrophil extracellular traps. Our research provides insights into mechanisms that regulate neutrophil recruitment during sterile lung inflammation and lays the foundation for developing new therapies.

24 March 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
FLFuyi Liao
Fuyi Liao
DSDavide Scozzi
Davide Scozzi
DZDequan Zhou
Dequan Zhou
MMMina Maksimos
Mina Maksimos
CDCamila Diedrich
Camila Diedrich
AGAndrew E. Gelman
Andrew E. Gelman
Neutrophils exacerbate pulmonary ischemia-reperfusion injury (IRI) resulting in poor short and long-term outcomes for lung transplant recipients. Glycolysis powers neutrophil activation, but it remains unclear if neutrophil-specific targeting of this pathway will inhibit IRI. Lipid nanoparticles containing the glycolysis flux inhibitor 2-deoxyglucose (2-DG) were conjugated to neutrophil-specific Ly6G antibodies (NP-Ly6G[2-DG]). Intravenously administered NP-Ly6G(2-DG) to mice exhibited high specificity for circulating neutrophils. NP-Ly6G(2-DG)-treated neutrophils were unable to adapt to hypoglycemic conditions of the lung airspace environment as evident by the loss of demand-induced glycolysis, reductions in glycogen and ATP content, and an increased vulnerability to apoptosis. NP-Ly6G(2-DG) treatment inhibited pulmonary IRI following hilar occlusion and orthotopic lung transplantation. IRI protection was associated with less airspace neutrophil extracellular trap generation, reduced intragraft neutrophilia, and enhanced alveolar macrophage efferocytotic clearance of neutrophils. Collectively, our data show that pharmacologically targeting glycolysis in neutrophils inhibits their activation and survival leading to reduced pulmonary IRI.

24 July 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
WLWenjun Li
Wenjun Li
HSHailey M. Shepherd
Hailey M. Shepherd
YTYuriko Terada
Yuriko Terada
ASAshley E. Shay
Ashley E. Shay
ABAmit I. Bery
Amit I. Bery
DKDaniel Kreisel
Daniel Kreisel
Neutrophils are the primary cell type involved in lung ischemia-reperfusion injury (IRI), which remains a frequent and morbid complication after organ transplantation. Endogenous lipid mediators that become activated during acute inflammation-resolution have gained increasing recognition for their protective role(s) in promoting the restoration of homeostasis, but their influence on early immune responses following transplantation remains to be uncovered. Resolvin D1, 7 S ,8 R ,17 S -trihydroxy-4 Z ,9 E ,11 E ,13 Z ,15 E ,19 Z -docosahexaenoic acid (RvD1), is a potent stereoselective mediator that exhibits proresolving and anti-inflammatory actions in the setting of tissue injury. Here, using metabololipidomics, we demonstrate that endogenous proresolving mediators including RvD1 are increased in human and murine lung grafts immediately following transplantation. In mouse grafts, we observe lipid mediator class switching early after reperfusion. We use intravital two-photon microscopy to reveal that RvD1 treatment significantly limits early neutrophil infiltration and swarming, thereby ameliorating early graft dysfunction in transplanted syngeneic lungs subjected to severe IRI. Through integrated analysis of single-cell RNA sequencing data of donor and recipient immune cells from lung grafts, we identify transcriptomic changes induced by RvD1. These results support a role for RvD1 as a potent modality for preventing early neutrophil-mediated tissue damage after lung IRI that may be therapeutic in the clinics.

5 February 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
FLFuyi Liao
Fuyi Liao
DZDequan Zhou
Dequan Zhou
MCMarlene Cano
Marlene Cano
ZLZhiyi Liu
Zhiyi Liu
DSDavide Scozzi
Davide Scozzi
AGAndrew E. Gelman
Andrew E. Gelman
How pathogens inhibit transplant tolerance remains unclear. Here, we found that Pseudomonas aeruginosa infection, but not other common bacterial respiratory infections, increases antibody-mediated rejection (AMR) risk in recipients of lung transplants. To explore this relationship, we performed orthotopic lung transplants in mice, infected recipients with P. aeruginosa , and observed for the development of AMR. Intravital two-photon microscopy showed that P. aeruginosa rapidly invaded bronchial-associated lymphoid tissues, which resulted in acute lymphocytotoxicity, including the death of forkhead box P3 (Foxp3) + CD4 + T cells that are required to suppress AMR. P. aeruginosa –mediated AMR required expression of the type III secretion system (T3SS), which injects exotoxins into the cell cytoplasm. Through a combination of mutagenesis and epitope tagging experiments, we revealed that T3SS exotoxin T ADP ribosyl-transferase activity was sufficient for graft-resident Foxp3 + CD4 + T cell apoptosis, leading to myeloid differentiation primary response 88 (Myd88)–dependent generation of T-box expressed in T cells (T-bet)– and C-X-C motif chemokine receptor 3 (CXCR3)–positive germinal center and memory B cells with high donor antigen avidity. We also found that T-bet + and CXCR3 + B cells were elevated in biopsies from recipients of lung transplants who were diagnosed with AMR. In mice, CXCR3 deficiency restricted to B cells or CXCR3 blockade prevented AMR despite P. aeruginosa infection. Our work has identified a previously unrecognized role of bacterial virulence in lung allograft rejection and suggests potential strategies to prevent AMR for those at high risk of P. aeruginosa infection after transplant.